Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Светлана Александровна ШейкоfiledCriticalСветлана Александровна Шейко
Priority to UAU201010381UpriorityCriticalpatent/UA53291U/en
Publication of UA53291UpublicationCriticalpatent/UA53291U/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
A method for treating endothelial dysfunction in the aged patients with the chronic heart failure comprises the standard therapy. In addition, Tivortin is administered intravenously dropwise, 100 mL of 4.2 % solution for 10-12 days, once a day followed by oral administration of the drug in a volume of 5 mL, 40 minutes before the meals thrice a day for three months. Furthermore, Nebivolol is administered per os at a daily dose of 4.2 mg for three months.
UAU201010381U2010-08-262010-08-26Method for treating endothelial dysfunction in aged patients with chronic heart failure
UA53291U
(en)